Objections from physicians are often seen as “hurdles” or a signal that inhibits a doctor to prescribe your brand. Your success as a professional will depend on your ability to anticipate and handle or overcome Physician objections. No matter how well rehearsed your detailing is, at the final stage of his decision, the doctor may […]
Category Archives: Blogs
What Is Health Information System (HIS) & its Importance?
A health information system (HIS) refers to a system designed to manage healthcare data. This includes systems that collect, store, manage and transmit a patient’s electronic medical record (EMR), a hospital’s operational management or a system supporting healthcare policy decisions. Health information systems also include those systems that handle data related to the activities of […]
Why Pharma Needs A New Approach To Patient Engagement In Drug Development
Customers are no longer content to buy a drug simply because of a doctor’s recommendation. In a study of 13,000 patients, 89% initiated a conversation with their physician about alternative treatment options, and 70% think decisions made about their treatment should be a collaborative effort with their doctor. While the pressure is on physicians, patient […]
Patient’s needs, satisfaction, and health related quality of life should be a focus for pharma.
Customers demand products that yield clear health benefits in everyday use, not just in the controlled setting of clinical trials. We focus our resources on developing medicines and devices that can produce positive real-world outcomes for patients and healthcare providers. Traditional approach to patient assessment, using clinical and laboratory evaluation, is largely based on observer […]
Internet of Things is Leading the Omnichannel Revolution for pharma companies
The rise of multichannel – Around the time of the Internet boom, however, things started to change. Websites and email were altering the way people accessed information. While at the same time, coincidentally, policies were becoming more restrictive regarding what life sciences companies could and couldn’t do for physicians. It was the perfect storm, and […]
Digital is reinventing the critical role of medical representatives in pharma marketing.
The pharmaceutical sales model has been shaken to its core recently, and it will be interesting to see what lasting changes will take effect after COVID restrictions in HCP’s offices begin to relax. With physician access rates deteriorating for the better part of a decade, the pandemic has only accelerated the journey for pharma sales […]
Push and Pull of Pharma Marketing, Which Strategy is Best for Pharma Companies
Pharma marketing used to be simple. A medicine arrived from R&D, you built the brand and developed brand-focused materials, then pushed it all out via the sales force. The customer was a nebulous figure, a member of the mass of doctors you met at a congress or company event, someone who greeted your reps with […]
How Advances in Cloud Computing Can Impact Big Data for Pharmacy
Pharma is known for its late adoption of new technologies. The industry thoroughly studies risks, pros and cons, etc., before adopting any new technology. But now as companies are being compelled to streamline their process and reduce costs, they are finding new ways to optimize complex processes by adopting cloud computing. The advances in cloud […]
Pharma firms turn to customer journey mapping strategies.
Business transformation, or its offspring–digital transformation–is sweeping across the pharma industry. In reality, most pharma companies been slower to embrace transformation than firms in many other industries, such as retail and CPG. Now pharma companies are either racing or at least marching double-time to catch up with new business models and customer expectations. As a […]
Virtual sales reps and physician’s engagement to remain the new normal.
Even if well underway before the pandemic, Covid-19 has given businesses an unprecedented opportunity to accelerate and implement technology-fueled changes to the way they operate and engage. For pharmaceutical companies, the pandemic forced many to rethink and readjust supply chains, clinical trials, manufacturing process and end-customer reach. If pharmaceutical companies had relied on the traditional […]